Cargando…
Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells wi...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172207/ https://www.ncbi.nlm.nih.gov/pubmed/15302851 http://dx.doi.org/10.1083/jcb.200405167 |
_version_ | 1782145027975151616 |
---|---|
author | Mikhailov, Alexei Shinohara, Mio Rieder, Conly L. |
author_facet | Mikhailov, Alexei Shinohara, Mio Rieder, Conly L. |
author_sort | Mikhailov, Alexei |
collection | PubMed |
description | When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells with hyperosmotic medium or a histone deacetylase inhibitor similarly delays entry into mitosis, and this delay can also be prevented by inhibiting p38. Together, these results reveal that agents or stresses that induce global changes in chromatin topology during G2 delay entry into mitosis, independent of the ATM-mediated DNA damage checkpoint, by activating the p38 MAPK checkpoint. The presence of this pathway obviates the necessity of postulating the existence of multiple “chromatin modification” checkpoints during G2. Lastly, cells that enter mitosis in the presence of topo II inhibitors form metaphase spindles that are delayed in entering anaphase via the spindle assembly, and not the p38, checkpoint. |
format | Text |
id | pubmed-2172207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21722072008-03-05 Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway Mikhailov, Alexei Shinohara, Mio Rieder, Conly L. J Cell Biol Research Articles When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells with hyperosmotic medium or a histone deacetylase inhibitor similarly delays entry into mitosis, and this delay can also be prevented by inhibiting p38. Together, these results reveal that agents or stresses that induce global changes in chromatin topology during G2 delay entry into mitosis, independent of the ATM-mediated DNA damage checkpoint, by activating the p38 MAPK checkpoint. The presence of this pathway obviates the necessity of postulating the existence of multiple “chromatin modification” checkpoints during G2. Lastly, cells that enter mitosis in the presence of topo II inhibitors form metaphase spindles that are delayed in entering anaphase via the spindle assembly, and not the p38, checkpoint. The Rockefeller University Press 2004-08-16 /pmc/articles/PMC2172207/ /pubmed/15302851 http://dx.doi.org/10.1083/jcb.200405167 Text en Copyright © 2004, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Research Articles Mikhailov, Alexei Shinohara, Mio Rieder, Conly L. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway |
title | Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway |
title_full | Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway |
title_fullStr | Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway |
title_full_unstemmed | Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway |
title_short | Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway |
title_sort | topoisomerase ii and histone deacetylase inhibitors delay the g2/m transition by triggering the p38 mapk checkpoint pathway |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172207/ https://www.ncbi.nlm.nih.gov/pubmed/15302851 http://dx.doi.org/10.1083/jcb.200405167 |
work_keys_str_mv | AT mikhailovalexei topoisomeraseiiandhistonedeacetylaseinhibitorsdelaytheg2mtransitionbytriggeringthep38mapkcheckpointpathway AT shinoharamio topoisomeraseiiandhistonedeacetylaseinhibitorsdelaytheg2mtransitionbytriggeringthep38mapkcheckpointpathway AT riederconlyl topoisomeraseiiandhistonedeacetylaseinhibitorsdelaytheg2mtransitionbytriggeringthep38mapkcheckpointpathway |